Harris et al., "Therapeutic antibodies -the coming of age", TIBTECH 11:42-42 Feb. 1993. |
Y. Abe, et al., "Expression of Membrane-associated Lymphotoxin/Tumor Necrosis Factor-.beta. on Human Lymphokine Killer Cells," Jpn. J. Canc. Res., 82, 23-26 (1991). |
Y. Abe, et al., "Studies of Membrane Associated And Soluble (Secreted) Lymphotoxin In Human Lymphokine-Activated T-Killer Cells In Vitro," Lymphokine and Cytokine Research, 11, pp. 115-121 (1992). |
B. Aggarwal et al., "Primary Structure of Human Lymphotoxin Derived From 1788 Lymphoblastoid Cell Line," J. Biol. Chem., 260, pp. 2334-2344 (1985). |
M. Akashi et al., "Lymphotoxin: Stimulation and Regulation of Colony-Stimulating Factors in Fibroblasts," Blood, 74, pp. 2383-2390 (1989). |
W.F. Anderson, "Human Gene Therapy," Science, 256, pp. 803-813 (1992). |
U. Andersson et al., "Characterization of Individual Tumor Necrosis Factor .alpha.-and .beta.-Producing Cells After Polyclonal T Cell Activation," J. of Immun. Meth., 123, pp. 233-240 (1989). |
J.S. Andrews et al., "Characterization of the Receptor for Tumor Necrosis Factor (TNF) and Lymphotoxin (LT) on Human T Lymphocytes," J. Immun., 144, pp. 2582-2591 (1990). |
R. Armitage et al., "Molecular And Biological Characterization Of A Murine Ligand For CD40," Nature, 357, pp. 80-82 (1992). |
K. Badenhoop et al., "TNF-.alpha. Gene Polymorphisms In Type 1 (Insulin-Dependent) Diabetes Mellitus" Diabetologia, 32, 445-448 (1989). |
B. Beutler et al., "The History, Properties, and Biological Effects of Cachectin," Biochemistry, 27, pp. 7575-7582 (1988). |
T. Bringman et al., "Monoclonal Antibodies to Human Tumor Necrosis Factors Alpha and Beta: Application for Affinity Purification, Immunoassays, and as Structural Probes," Hybridoma, 6, pp. 489-507 (1987). |
J. Browning et al., "Studies On The Differing Effects Of Tumor Necrosis Factor And Lymphotoxin On The Growth Of Several Human Tumor Lines," J. Immun., 143, pp. 1859-1867 (1989). |
D. Cavender et al., "Endothelial Cell Activation Induced By Tumor Necrosis Factor And Lymphotoxin," Amer. J. Path., 134, pp. 551-560 (1989). |
N. Damle et al., "Distinct Regulatory Effects of IL-4 and TNF-.alpha. During CD3-Dependent and CD3-Independent Initiation Of Human T-Cell Activation," Lymph Res., 8, pp. 85-97 (1989). |
M. Eck et al., "The Structure Of Tumor Necrosis Factor-.alpha. At 2.6.ANG. Resolution, Implications For Receptor Binding," J. Biological Chemistry, 264, 29, pp. 17595-17605 (1989). |
M. Eck et al., "The Structure of Human Lymphotoxin (Tumor Necrosis Factor-.beta.) At 1.9-.ANG. Resolution," J. Biological Chemistry, 267, 4 pp. 2119-2122 (1992). |
T. Farrah et al., "Emerging Cytokine Family," Nature, 358, p. 26 (1992). |
G. Fuh et al., "Rational Design Of Potent Antagonists To The Human Growth Hormone Receptor," Science, 256 pp. 1677-1680 (1992). |
D. Goeddel et al., "Tumor Necrosis Factors: Gene Structure and Biological Activities," Cold Spring Harbor Symposia on Quant. Biol., 51, pp. 597-609 (1986). |
G. A. Granger et al., "Lymphocyte In Vitro Cytotoxicity: Mechanisms Of Immune And Non-Immune Small Lymphocyte Mediated Target L Cell Destruction," Jour. of Immun., 101, pp. 111-120 (1968). |
P. Gray, "Molecular Characterization of Human Lymphotoxin," Lymphokines, 13, pp. 199-208 (1987). |
P. Gray et al., "Cloning and Expression of cDNA For Human Lymphotoxin, A Lymphokine With Tumor Necrosis Activity," Nature, 312, pp. (721-724) (1984). |
L. Green et al., "Rapid Colorimetric Assay for Cell Viability: Application to the Quantitation of Cytotoxic and Growth Inhibitory Lymphokines," J. of Immun. Meth., 70, pp. 257-268 (1984). |
J. Hiserodt et al., "Identification of Membrane-Associated Lymphotoxin (LT) on Mitogen-Activated Human Lymphocytes Using Heterologous Anti-LT Antisera in Vitro," Cell. Immun., 34, pp. 326-339 (1977). |
N. Itoh et al., "The Polypeptide Encoded By The cDNA For Human Cell Surface Antigen FAS Can Mediate Apoptosis," Cell 66, pp. 233-243 (1991). |
E. Jones et al., "Structure Of Tumor Necrosis Factor," Nature, 333, pp. 225-228 (1989). |
A. Kasid et al., "Human Gene Transfer: Characterization of Human Tumor-Infiltrating Lymphocytes As Vehicles For Retroviral-Mediated Gene Transfer In Man," Proc. Natl. Acad. Sci. USA, 87, pp. 473-477 (1990). |
M. Kinkhabwala et al., "A Novel Addition To The T Cell Repertory," J. Exp. Med., 171, pp. 941-946 (1990). |
M. Kriegler et al., "A Novel Form of TNF/Cachectin Is A Cell Surface Cytotoxic Transmembrane Protein: Ramifications For the Complex Physiology of TNF," Cell, 53, pp. 45-53 (1988). |
Liang et al., "Production And Characterization of Monoclonal Antibodies Against Recombinant Human Tumor Necrosis Factor/Cachectin," Biochem. Biophys. Res. Comm., 137, pp. 847-854 (1986). |
S. Mallet et al., "A New Superfamily Of Cell Surface Proteins Related To The Nerve Growth Factor Receptor," Immunology Today, 12, pp. 220-223 (1991). |
L.J. Old, "Tumor Necrosis Factor (TNF)," Science, 230, pp. 630-632 (1985). |
N. Paul et al., "Lymphotoxin," Ann. Rev. Immun., 6, pp. 407-438 (1988). |
N. Paul et al., "Lymphotoxin Activation by Human T-Cell Leukemia Virus Type I-Infected Cells Lines: Role NF-kB," J. Virol., 64, pp. 5412-5419 (1990). |
D. Pennica et al., "Human Tumor Necrosis Factor: Precursor Structure, Expression And Homology To Lymphotoxin," Nature, 312, pp. 724-729 (1984). |
A. Peterson et al., "Monoclonal Antibody and Ligand Binding Sites Of The T Cell Erythrocyte Receptor (CD2)," Nature, 329, pp. 842-846 (1987). |
F. Pociot et al., "A Tumor Necrosis Factor Beta Gene Polymorphism In Relation To Monokine Secretions And Insulin-Dependent Diabetes Mellitus," Scand. J. Immunol., 33, pp. 37-49 (1991). |
G. Ranges et al., "Tumor Necrosis Factor-.alpha. As A Proliferative Signal For An IL-2 Dependent T Cell Line: Strict Species Specificity of Action," J. of immun., 142, pp. 1203-1208 (1989). |
G. Ranges et al., "Tumor Necrosis Factor .alpha./Cachectin Is A Growth Factor For Thymocytes," J. Exp. Med., 167, pp. 1472-1478 (1988). |
G.D. Roodman et al., "Tumor Necrosis Factor-alpha and Hematopoietic Progenitors: Effects of Tumor Necrosis Factor on the Growth of Erythroid Progenitors CFU-E and BFU-E and Hematopoietic Cell Lines K562, HL60, and HEL Cells," Exp. Hematology, 15, pp. 928-935 (1987). |
S. Rosenberg et al., "Special Report Use Of Tumor-Infiltrating Lymphocytes And Interleukin-2 In the Immunotherapy of Patients With Metastatic Melanoma," New Eng. Jour. of Med., 319, pp. 1676-1680 (1988). |
N. Ruddle, "Lymphotoxin Redux," Immun. Today, 6, pp. 156-159 (1985). |
N. Ruddle et al., "The Role of Lymphotoxin in Inflammation," Prog. Allergy, 40, pp. 162-182 (1988). |
K. Sastry et al., "HIV-1 tat Gene Induces Tumor Necrosis Factor-.beta. (Lymphotoxin) In A Human B-lymphoblastoid Cell Line," J. Biol. Chem., 265, pp. 20091-20093 (1990). |
T. Schall et al., "Molecular Cloning And Expression Of A Receptor For Human Tumor Necrosis Factor," Cell, 61, pp. 361-370 (1990). |
P. Scheurich et al., "Immunoregulatory Activity Of Recombinant Human Tumor Necrosis Factor (TNF)-.alpha.: Induction Of TNF Receptors On Human T Cells And TNF-.alpha.-Mediated Enhancement Of T Cell Responses," J. Immun., 138 pp. 1786-1790 (1987). |
M. Shalaby et al., "The Involvement of Human Tumor Necrosis Factors-.alpha.And -.beta.In The Mixed Lymphocyte Reaction," J. Immun., 141, pp. 499-503 (1988). |
M. Sigel, et al., "Production of Antibodies by Inoculation into Lymph Nodes," Meth. in Enz., 93, pp. 3-12 (1983). |
C. Smith et al., "A Receptor For Tumor Necrosis Factor Defines An Unusual Family Of Cellular And Viral Proteins," Science, 248, pp. 1019-1023 (1990). |
D. Spriggs et al., "Tumor Necrosis Factor Expression In Human Epithelial Tumor Cell Lines," J. Clin. Inves., 81, pp. 455-460 (1988). |
J. Tavernier et al., "Conserved Residues Of Tumor Necrosis Factor And Lymphotoxin Constitute The Framework Of The Trimeric Structure," Fed. Eur. Biochem. Soc. Letters, 257, pp. 315-318 (1989). |
H. Thomas, et al., "Biological Approaches to Cancer Therapy," J. Int. Med. Res., 17, pp. 191-204 (1989). |
M. Turner et al., "Human T Cells From Autoimmune and Normal Individuals Can Produce Tumor Necrosis Factor," Eur. J. Immun. 17, pp. 1807-1814 (1987). |
E. Tschachler et al., Human Retrovirology, Raven Press, pp. 105-113, (1990). |
R. Watanabe-Fukunaga et al., "Lymphoproliferation Disorder In Mice Explained By Defects In Fas Antigen That Mediates Apoptosis," Nature, 356, pp. 314-317 (1992). |
C. Ware et al., "Human T Cell Hybridomas Producing Cytotoxic Lymphokines: Induction of Lymphotoxin Release and Killer Cell Activity by Anti-CD3 Monoclonal Antibody or Lectins and Phorbol Ester," Lymphokine Res., 5, pp. 313-324 (1986). |
C. Ware et al., "Regulation Of The CTL Lytic Pathway By Tumor Necrosis Factor," Cellular Immunity And The Immunotherapy Of Cancer, UCLA Symposia on Molecular and Cell Biology M.T. Lotze and O.J. Finn, Eds. Vol. 135, pp. 121-128 (Wiley-Liss, Inc. New York) 1990. |
L. Wysocki, U. Sato, "Panning for Lymphocytes: A method for Cell Selection," Proc. Natl. Acad. Sci. USA, 75, pp. 2844-2848 (1978). |
H. Yamanaka et al., "Identity of Human B-cell Line Cytotoxic Lymphokine With Tumor Necrosis Factor Type .beta.," Proc. Natl. Acad. Sci. USA, 86, pp. 1343-1347 (1989). |